Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Low-dose transdermal testosterone tested in chronic stable angina

Aug. 30, 2000

Results of dosing studies on tezosentan in CHF reported

Aug. 29, 2000

Mast cell tryptase explored as a marker in stable CAD

Aug. 29, 2000

V1A/V2 receptor antagonist conivaptan in the news

Aug. 29, 2000

Hormone replacement therapy shows no cardiovascular benefits in older women

Aug. 29, 2000

Orally bioavailable potassium (IKs) blockers synthesized by Bristol-Myers Squibb

Aug. 29, 2000

Ceramide-coated catheters significantly reduce restenosis in vivo

Aug. 29, 2000

Chymase inhibition -- a route to cardiovascular drug discovery

Aug. 28, 2000

Individuals with manic depression may have lower heart attack risks

Aug. 28, 2000

Spironolactone improves survival in CHF, possibly by limiting cardiac fibrosis

Aug. 28, 2000

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...